Tower Research Capital (TRC)’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27
| Closed | -$73 | – | 6006 |
|
|
2023
Q2 | $73 | Buy |
+27
| New | +$73 | ﹤0.01% | 5816 |
|
|
2023
Q1 | – | Sell |
-113
| Closed | – | – | 5918 |
|
|
2022
Q4 | $0 | Sell |
113
-16,647
| -99% | – | ﹤0.01% | 5996 |
|
|
2022
Q3 | $30K | Sell |
16,760
-5,208
| -24% | -$9.32K | ﹤0.01% | 3596 |
|
|
2022
Q2 | $69K | Buy |
21,968
+21,513
| +4,728% | +$67.6K | ﹤0.01% | 2590 |
|
|
2022
Q1 | $3K | Buy |
455
+104
| +30% | +$686 | ﹤0.01% | 5362 |
|
|
2021
Q4 | $5K | Sell |
351
-6,539
| -95% | -$93.1K | ﹤0.01% | 5145 |
|
|
2021
Q3 | $55K | Buy |
+6,890
| New | +$55K | ﹤0.01% | 2874 |
|
|
2020
Q1 | – | Sell |
-89
| Closed | – | – | 3252 |
|
|
2019
Q4 | $0 | Sell |
89
-111
| -56% | – | ﹤0.01% | 3748 |
|
|
2019
Q3 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 3843 |
|
|
2018
Q4 | – | Sell |
-400
| Closed | -$1K | – | 3934 |
|
|
2018
Q3 | $1K | Buy |
400
+200
| +100% | +$500 | ﹤0.01% | 3577 |
|
|
2018
Q2 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 3474 |
|
|
2017
Q2 | – | Sell |
-20
| Closed | -$1K | – | 2921 |
|
|
2017
Q1 | $1K | Sell |
20
-90
| -82% | -$4.5K | ﹤0.01% | 2780 |
|
|
2016
Q4 | $5K | Buy |
110
+21
| +24% | +$955 | ﹤0.01% | 3029 |
|
|
2016
Q3 | $5K | Buy |
89
+5
| +6% | +$281 | ﹤0.01% | 2537 |
|
|
2016
Q2 | $5K | Buy |
84
+15
| +22% | +$893 | ﹤0.01% | 3366 |
|
|
2016
Q1 | $4K | Buy |
69
+29
| +73% | +$1.68K | ﹤0.01% | 2873 |
|
|
2015
Q4 | $5K | Hold |
40
| – | – | ﹤0.01% | 2958 |
|
|
2015
Q3 | $5K | Buy |
+40
| New | +$5K | ﹤0.01% | 2786 |
|